Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GGT isoforms in dyslipidemic patients receiving lipid-lowering therapy
2007-007491-42Phase 4Completed
- Sponsor
- Institute of Clinical Physiology
- Start
- Apr 2008
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of rosuvastatin, simvastatin, atorvastatin and gemfibrozil in dyslipidemia, hypercholesterolemia and hypertriglyceridemia (4 arms), sponsored by Institute of Clinical Physiology. Primary endpoints: Profile of GGT isoforms and Effect of lipid-lowering treatment on total and subfraction GGT activity. Started Apr 2008; status: completed.
02
Drugs
rosuvastatinsimvastatinatorvastatingemfibrozil
03
Conditions
dyslipidemiahypercholesterolemiahypertriglyceridemia
Beyond the preview
Go deeper on 2007-007491-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007491-42.